Targeting BTK in CLL: Expert Guidance on Selecting Single-Agent and Combination Therapy

Download All
Learn how global experts plan optimal BTK inhibitor–based therapy for patients with CLL with downloadable slides and an on-demand webcast from the CCO webinar at the 2021 XIX iwCLL Congress.
Richard R. Furman, MD

Downloadable Slides and Clinical ExpressPoints

Download this slideset on the current role of BTK inhibitors in the treatment of patients with CLL.

Richard R. Furman, MD Released: September 27, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue